Erik Harris, EVP & Chief Commercial Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 10,539 shares at $22.80 ($240K) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Seasonal sale ($240k) by EVP & Chief Commercial Officer — this insider has traded RARE in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| RARE | SELL | 2023-09-06 | $228K | — | Filing → |
| RARE | SELL | 2023-06-21 | $15K | — | Filing → |
| RARE | SELL | 2023-03-03 | $166K | — | Filing → |